Growth capital for RealFaceValue

RealFaceValue

RealFaceValue (RFV) offers an innovative cloud-based software solution that can generate a scientifically validated scan of our face. This scan reveals an intuitive interpretation regardless of gender and/or ethnicity.

• Dutch MedTech company RealFaceValue was founded in 2020. The founders have combined more than 50 years of experience in aesthetic treatments, behavioral science and artificial intelligence.
• RealFaceValue offers a software tool that sets a new standard: Perceptive Intelligence, the ability to perceive, understand and optimize first impressions.
• The tool is initially being launched in the medical aesthetics market, but there is the possibility of further expansion into the cosmetics market and beyond.
• It supports clients in making an informed decision regarding their aesthetic needs based on perception and social impact.

Investors

• RealFaceValue has successfully secured €1.5 million in growth capital from a consortium of seven investors.
• The tool is currently being implemented by three leading Dutch medical aesthetic clinics. The funding will support the company's introduction to the Dutch market and further optimization of the software tool in anticipation of its global rollout.
• RealFaceValue operates on a SaaS (Software as a Service) business model, where customers subscribe to a monthly payment plan to gain access to a predetermined number of facial scans.
• The seven investors provided growth capital through an equity stake in RealFaceValue.
• The funds will be used for market launch, optimization of the software tool, international expansion and professionalization of the company.
• JBR helped prepare an investor presentation, set up a financial model, identify and approach potential investors, as well as negotiate and advise on structuring the deal, preparing the term sheet and final transaction documentation.